Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|February 22, 2008
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approachPhilip Funovic, Mykhaylo Korda, Ruslan Kubant, et al.Journal of Clinical Lipidology|June 30, 2022
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-ITPrakriti Gaba, Deepak L Bhatt, R Preston Mason, et al.Trends in Pharmacological Sciences|December 22, 2015
Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDARoger Bate, Aparna Mathur, Harry M Lever, et al.Journal of the American College of Cardiology|March 22, 2008
Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT studyMary F Walter, Robert F Jacob, Rebekah E Bjork, et al.Journal of Atherosclerosis and Thrombosis|June 15, 2011
Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese ratsR Preston Mason, Robert F Jacob, Ruslan Kubant, et al.Journal of the American College of Cardiology|November 16, 2004
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT studyMary F Walter, Robert F Jacob, Barrett Jeffers, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 25, 2004
Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipineMark B Kahn, Kathleen Boesze-Battaglia, David W Stepp, et al.Journal of Lipid Research|April 23, 2004
Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitorRichard J Cenedella, Robert Jacob, Douglas Borchman, et al.Journal of Cardiovascular Pharmacology|June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicityR Preston Mason, Mary F Walter, Hyesun P McNulty, et al.Pharmaceutical Research|December 19, 2007
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunctionR Preston Mason, Ruslan Kubant, Gehan Heeba, et al.Pageof 10